Emerging Company Profile

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Bugworks: breaking the U.S.-centric antimicrobial mold</h1><h2 class="title-bottom webtitle">Bugworks&#x2019; broad-spectrum antibiotics inhibit DNA replication while avoiding common resistance mechanism</h2><div class="byline">Elizabeth S. Eaton, Staff Writer</div><div class="date"></div></div></div></div>

Bugworks Research Inc.

Bugworks: breaking the U.S.-centric antimicrobial mold

Bugworks plans to bring a new class of broad-spectrum antibiotics to both Western and developing markets.  

Bugworks’ broad-spectrum antibiotics inhibit DNA replication while avoiding common resistance mechanism

Featured Analysis

Articles

Current Editions

Data Graphics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

China Healthcare Summit

Bio€quity Europe

Events

My Workspace

Company Overview

Management

Editorial & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Trial

Subscribe

Advertising & Sponsorship

Career Opportunities

Customer Resource Center

Contact

Home

<br/><center><span style="font-size:1.75rem;font-weight:500;">Access This Article</span></center>

Paywall Not Entitled Title

Request a Trial

Purchase This Article

<center><span style="font-weight:300;">[Subscribers Log in]{{login}}</span></center>

Paywall Sub log in